Association of BMI, Smoking, and Alcohol with Multiple Myeloma Mortality in Asians: A Pooled Analysis of More than 800,000 Participants in the Asia Cohort Consortium
Open Access
- 1 November 2019
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 28 (11), 1861-1867
- https://doi.org/10.1158/1055-9965.epi-19-0389
Abstract
To date, few epidemiologic studies have been conducted to elucidate lifestyle-related risk factors for multiple myeloma in Asia. We investigated the association of body mass index (BMI), smoking, and alcohol intake with the risk of multiple myeloma mortality through a pooled analysis of more than 800,000 participants in the Asia Cohort Consortium. The analysis included 805,309 participants contributing 10,221,623 person-years of accumulated follow-up across Asia Cohort Consortium cohorts. HRs and 95% confidence intervals (95% CI) for the association between BMI, smoking, and alcohol at baseline and the risk of multiple myeloma mortality were assessed using a Cox proportional hazards model with shared frailty. We observed a statistically significant dose-dependent association between BMI categories and the risk of multiple myeloma mortality (2: HR = 0.80, 95% CI: 0.52–1.24; 18.5–24.9 kg/m2: reference; 25.0–29.9 kg/m2: HR = 1.17, 95% CI: 0.94–1.47; ≥30 kg/m2: HR = 1.61, 95% CI: 0.99–2.64, Ptrend = 0.014). By sex, this association was more apparent in women than in men (P for heterogeneity between sexes = 0.150). We observed no significant associations between smoking or alcohol consumption and risk of multiple myeloma mortality. This study showed that excess body mass is associated with an increased risk of multiple myeloma mortality among Asian populations. In contrast, our results do not support an association between smoking or alcohol consumption and the risk of multiple myeloma mortality in Asian populations. This study provides important evidence on the association of BMI, smoking, and alcohol with the risk of multiple myeloma mortality in Asian populations.Funding Information
- NCI (R01 CA082729, UM1 CA173640)
- NCI (R37 CA070867, UM1CA182910)
- National Cancer Center Research and Development (23-A-31, 26-A-2)
- NCI (R01CA144034, UM1CA182876)
This publication has 39 references indexed in Scilit:
- Global Burden of Multiple MyelomaJAMA Oncology, 2018
- Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese IndividualsCancer Research, 2016
- Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studiesBritish Journal of Haematology, 2014
- Alcohol drinking and multiple myeloma risk – a systematic review and meta-analysis of the dose–risk relationshipEuropean Journal of Cancer Prevention, 2014
- The Role of Adiponectin in Cancer: A Review of Current EvidenceEndocrine Reviews, 2012
- Sex-differences in adiponectin levels and body fat distribution: Longitudinal observations in Afro-JamaicansDiabetes Research and Clinical Practice, 2010
- Ethnic Variation in Adiponectin and Leptin Levels and Their Association With Adiposity and Insulin ResistanceDiabetes Care, 2010
- Association of Alcohol Intake with the Risk of Malignant Lymphoma and Plasma Cell Myeloma in Japanese: A Population-Based Cohort Study (Japan Public Health Center–based Prospective Study)Cancer Epidemiology, Biomarkers & Prevention, 2010
- Impact of Body Mass Index on the Risk of Total Cancer Incidence and Mortality Among Middle-Aged Japanese: Data from a Large-Scale Population-Based Cohort Study – The JPHC StudyCancer Causes & Control, 2004
- Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosisProceedings of the National Academy of Sciences of the United States of America, 2004